As of 2025-11-01, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (65.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.73 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -346.3%.
The range of the Relative Valuation is (56.51) - (67.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 22.5x | 19.9x |
| Forward P/E multiples | 18.8x - 29.0x | 23.9x |
| Fair Price | (56.51) - (67.75) | (65.82) |
| Upside | -311.4% - -353.5% | -346.3% |
| Date | P/E |
| 2025-10-30 | -8.65 |
| 2025-10-29 | -8.65 |
| 2025-10-28 | -9.00 |
| 2025-10-27 | -9.11 |
| 2025-10-24 | -8.89 |
| 2025-10-23 | -8.74 |
| 2025-10-22 | -8.89 |
| 2025-10-21 | -9.29 |
| 2025-10-20 | -9.21 |
| 2025-10-17 | -8.93 |
| 2025-10-16 | -8.83 |
| 2025-10-15 | -9.10 |
| 2025-10-14 | -8.81 |
| 2025-10-13 | -9.03 |
| 2025-10-10 | -8.91 |
| 2025-10-09 | -9.16 |
| 2025-10-08 | -9.06 |
| 2025-10-07 | -8.72 |
| 2025-10-06 | -8.78 |
| 2025-10-03 | -8.79 |
| 2025-10-02 | -8.60 |
| 2025-10-01 | -8.41 |
| 2025-09-30 | -8.61 |
| 2025-09-29 | -8.71 |
| 2025-09-26 | -8.70 |
| 2025-09-25 | -8.40 |
| 2025-09-24 | -8.52 |
| 2025-09-23 | -8.06 |
| 2025-09-22 | -8.27 |
| 2025-09-19 | -8.19 |
| 2025-09-18 | -8.62 |
| 2025-09-17 | -8.14 |
| 2025-09-16 | -8.18 |
| 2025-09-15 | -8.15 |
| 2025-09-12 | -8.13 |
| 2025-09-11 | -8.38 |
| 2025-09-10 | -8.30 |
| 2025-09-09 | -8.08 |
| 2025-09-08 | -7.79 |
| 2025-09-05 | -7.61 |
| 2025-09-04 | -7.58 |
| 2025-09-03 | -7.86 |
| 2025-09-02 | -7.34 |
| 2025-08-29 | -7.35 |
| 2025-08-28 | -7.45 |
| 2025-08-27 | -7.52 |
| 2025-08-26 | -7.24 |
| 2025-08-25 | -7.30 |
| 2025-08-22 | -7.47 |
| 2025-08-21 | -7.33 |